Ledger.Open graph →
SEC Form D · filed September 16, 2024

ONL Therapeutics, Inc

Offering
$65.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Ann Arbor, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Bill Burns · Ann Arbor, MIDirectorDavid Zacks · Ann Arbor, MIExecDavid Esposito · Ann Arbor, MIExec · DirectorConstance Chang · Ann Arbor, MIExecMarian Nakada · Watertown, MADirectorSeth E. Roderick · Harrisonburg, VAExecSean E. Foster · San Juan, Puerto RicoExec · DirectorMiguel E. Prendens · Winchester, VADirectorGreg E. White · Fernandina Beach, FLExecAaron Fletcher · St. Paul, MNDirectorMichal Silverberg · Cambridge, MADirectorAri A. Santiago · Clayton, MODirectorHarold A. Thomas, Jr · Clayton, MOExecJames L. Alt · New York, NYExec · DirectorDavid Tingley · Naples, FLExecAaron Fletcher · St. Paul, MNDirectorMichal Silverberg · Menlo Park, CADirectorMarian Nakada · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗